| Literature DB >> 26388675 |
Sein Lee1, Jong-Eun Kim1, Sujin Suk2, Oh Wook Kwon3, Gaeun Park1, Tae-Gyu Lim1, Sang Gwon Seo1, Jong Rhan Kim1, Dae Eung Kim4, Miyeong Lee5, Dae Kyun Chung6, Jong Eun Jeon4, Dong Woon Cho4, Byung Serk Hurh4, Sun Yeou Kim7, Ki Won Lee8.
Abstract
Skin hydration is one of the primary aims of beauty and anti-aging treatments. Barley (Hordeum vulgare) and soybean (Glycine max) are major food crops, but can also be used as ingredients for the maintenance of skin health. We developed a natural product-based skin treatment using a barley and soybean formula (BS) incorporating yeast fermentation, and evaluated its skin hydration effects as a dietary supplement in a clinical study. Participants ingested a placebo- (n = 33) or BS- (3 g/day) containing drink (n = 32) for 8 weeks. A significant increase in hydration in the BS group as compared to the placebo group was observed on the faces of subjects after 4 and 8 weeks, and on the forearm after 4 weeks. Decreases in stratum corneum (SC) thickness were also observed on the face and forearm. BS enhanced hyaluronan (HA) and skin barrier function in vitro and reduced Hyal2 expression in human dermal fibroblasts (HDF). BS also recovered ultraviolet (UV) B-induced downregulation of HA in HaCaT cells. These results suggest that BS has promising potential for development as a health functional food to enhance skin health.Entities:
Keywords: barley; hyaluronan; skin hydration; soybean; ultraviolet B
Year: 2015 PMID: 26388675 PMCID: PMC4566027 DOI: 10.3164/jcbn.15-43
Source DB: PubMed Journal: J Clin Biochem Nutr ISSN: 0912-0009 Impact factor: 3.114
Drink preparation for clinical trial
| Materials | Placebo group | Experimental group | ||
|---|---|---|---|---|
| Mixing Ratio (%) | Amount per day (g) | Mixing Ratio (%) | Amount per day (g) | |
| BS | 0 | 0 | 3 | 3 |
| Water | 95.24 | 95.24 | 92.24 | 92.24 |
| Roasted unpolished rice extract | 1 | 1 | 1 | 1 |
| Fructooligosaccarides | 2 | 2 | 2 | 2 |
| Cereal flavor | 1 | 1 | 1 | 1 |
| Lotus leaf extract | 0.3 | 0.3 | 0.3 | 0.3 |
| Rice flavor | 0.2 | 0.2 | 0.2 | 0.2 |
| Enzyme treated stevia | 0.06 | 0.06 | 0.06 | 0.06 |
| Pectin | 0.1 | 0.1 | 0.1 | 0.1 |
| Dextrin | 0.1 | 0.1 | 0.1 | 0.1 |
| Sum | 100 | 100 | 100 | 100 |
Fig. 1Fermented barley and soybean formula (BS) enhances skin hydration in healthy subjects. (A) Clinical study design. (B) Body weight did not change significantly as a result of BS treatment. (C) and (D) BS enhances skin hydration on the face (C) and forearm (D). The clinical study was conducted as described in Materials and Methods. Skin hydration was measured using a Corneometer® CM825. Open circle = placebo group, closed circle = BS group. Data represent mean values ± SD. P values were determined with student’s t test.
Fig. 2BS reduces stratum corneum thickness in healthy subjects. (A) and (B) Stratum corneum images of placebo and BS-treated subjects taken at the indicated time points. Quantification of stratum corneum using D-squame® Black Tape on the face (A) and forearm (B). (C) and (D) quantification of the stratum corneum in face (C) and forearm (D) images using Image-Pro® Plus software (Media Cybernetics Inc, MD). The open circle represents the placebo group and closed circle represents the BS group. Data represent mean values ± SD. P values were determined using student’s t test.
Fig. 3BS enhances hyaluronan (HA) content via inhibition of HYAL2 in human dermal fibroblasts (HDF). (A) BS enhances HA content in HDFs. HDF cells were starved in serum-free media and treated with BS at the indicated concentrations for 48 h. HA concentrations were determined by ELISA as described in Materials and Methods. (B), (C), (D), (E) and (F) effects of BS on mRNA expression of an HA-regulatory enzyme in HDF cells. HDF cells were starved in serum-free media and treated with BS at the indicated concentrations for 24 h. mRNA levels of HAS1 (B), HAS2 (C), HAS3, HYAL1 (E) and HYAL2 (F) were analyzed by real-time RT-PCR using specific primers as described in Materials and Methods. (G) HA reduces HYAL2 protein expression in HDF cells. HDF cells were starved in serum-free media and treated with BS at the indicated concentrations for 48 h. HYAL2 and β-actin expression were determined by Western blot analysis as described in Materials and Methods. Data represent mean values ± SD. *p<0.05 vs the non-treated control.
Fig. 4BS recovers ultraviolet (UV) B-induced downregulation of a barrier function related gene in HaCaT cells. After 1 h of BS treatment, cells were irradiated with 0.01 J/cm2 UVB. Protein was harvested after 24 h and detected with specific antibodies by Western blot as described in Materials and Methods.
Fig. 5BS enhances HA expression via recovery of HAS2 protein in UVB-treated HaCaT cells. (A) BS upregulates HA content in UVB-treated HaCaT cells. After 1 h of BS treatment, cells were irradiated with 0.01 J/cm2 UVB. Media was collected after 48 h. HA concentrations were determined by ELISA as described in Materials and Methods. (B), (C), (D), (E) and (F) effects of BS treatment on mRNA expression of an HA regulatory enzyme in UVB-treated HaCaT cells. mRNA was harvested after 48 h. mRNA levels of HAS1 (B), HAS2 (C), HAS3, HYAL1 (E) and HYAL2 (F) were analyzed by real-time RT-PCR using specific primers as described in Materials and Methods. (G) HA reduces HYAL2 protein expression in HaCaT cells. HaCaT cells were starved in serum-free media and treated with BS at the indicated concentrations for 48 h. HAS2 and β-actin expression were determined by Western blot as described in Materials and Methods. Data represent mean values ± SD. *p<0.01 vs the UVB-treated control; #p<0.01 vs the non-treated control.